Abstract

TREATMENT OF SIX PATIENTS WITH MALIGNANT MESOTHELIOMA WITH THE GENE MODIFIED CELL LINE PA1‐STK

Authors: Lynn H. Harrison MD, Paul O. Schwarzenberger MD, Scott M. Freeman MD, Aizen J. Marrogi MD, Rajagopal Ramesh PhD, Patrick S. Byrne PhD, Chris G. Theodossiou MD, Richard H. Gaumer MD, Warren R. Summer MD, Ann B. Weinacker MD, Jay K. Rolls MD

Abstract

Annual Supplement of Abstracts and Poster Presentations: 92nd Annual Scientific Assembly (1998)

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References